SUVEN PHARMACEUTICALS LIMITED
SUVEN PHARMACEUTICALS LIMITED is a Public Limited Company, incorporated under the Companies Act as a Company limited by Shares. It is classified as Non-govt company and is registered at RoC-Hyderabad.
There are 3 promoter(s) of the company viz.GOVINDA PRASAD DASU, SUBBA RAO PARUPALLY, SUNDER VENKATRAMAN .
SUVEN PHARMACEUTICALS LIMITED Annual General Meeting (AGM) was last held on as per records from the Ministry of Corporate Affairs (MCA).
Financial Details & Insights
The authorized share capital of the company is Rs.10,00,000 and its paid up capital is Rs.1,00,000. Its balance sheet was last filed on None. SUVEN PHARMACEUTICALS LIMITED Corporate Identification Number (CIN) is U24299TG2018PLC128171 and its registration number is 128171.
Contact Details & Insights
You can contact them by emailing at info@suven.com. The companies registered address is # 8-2-334, SDE SERENE CHAMBERS, 6th FLOOR AVENUE 7, ROAD NO. 5, BANJARA HILLS HYDERABAD Hyderabad TG 500034 IN.
Other Details & Information
SUVEN PHARMACEUTICALS LIMITED's status is Active as per the records. The company is Unlisted.
CIN | U24299TG2018PLC128171 |
Company Name | SUVEN PHARMACEUTICALS LIMITED |
ROC Code | RoC-Hyderabad |
Registration Number | 128171 |
Company Category | Company limited by Shares |
Company SubCategory | Non-govt company |
Class of Company | Public |
Authorised Capital(Rs) | 10,00,000 |
Paid up Capital(Rs) | 1,00,000 |
Number of Members (Applicable in case of company without Share Capital) | 0 |
Date of Incorporation | 06-11-2018 |
Registered Address | # 8-2-334, SDE SERENE CHAMBERS, 6th FLOOR AVENUE 7, ROAD NO. 5, BANJARA HILLS HYDERABAD Hyderabad TG 500034 IN |
Email Id | info@suven.com |
Whether Listed or not | Unlisted |
Date of Last AGM | |
Date of Balance Sheet | |
Company Status (for efiling) | Active |
Last Updated On | 19-04-2019 |
Directors/Signatory Details
DIN/PAN | Name | Begin Date |
---|---|---|
00160408 | GOVINDA PRASAD DASU | 06-11-2018 |
00296951 | SUBBA RAO PARUPALLY | 06-11-2018 |
00300628 | SUNDER VENKATRAMAN | 06-11-2018 |